The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Clinical Characteristics of Somatic Mutations in Chinese Patients With Aldosterone-Producing Adenoma
Open accessAbstract
Recent studies have shown that somatic mutations in the KCNJ5, ATP1A1, ATP2B3, and CACNA1D genes are associated with the pathogenesis of aldosterone-producing adenoma. Clinical profile and biochemical characteristics of the mutations in Chinese patients with aldosterone-producing adenoma remain unclear. In this study, we performed DNA sequencing in 168 Chinese patients with aldosterone-producing adenoma and found 129 somatic mutations in KCNJ5, 4 in ATP1A1, 1 in ATP2B3, and 1 in CACNA1D. KCNJ5 mutations were more prevalent in female patients and were associated with larger adenomas, higher aldosterone excretion, and lower minimal serum K(+) concentration. More interestingly, we identified a novel somatic KCNJ5 mutation (c.445-446insGAA, p.T148-T149insR) that could enhance CYP11B2 mRNA upregulation and aldosterone release. This mutation could also cause membrane depolarization and intercellular Ca(2+) increase. In conclusion, somatic KCNJ5 mutations are conspicuously more popular than mutations of other genes in aldosterone-producing adenomas of Chinese patients. The T148-T149insR mutation in KCNJ5 may influence K(+) channel selectivity and autonomous aldosterone production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in KCNJ5 (potassium channel) have been documented in patients with aldosterone-producing adenomas in approximately 40% of patients (151) from European cohorts, though much higher rates are reported in patients from Japan and Asia (152,153).”
From Adrenal incidentaloma (2020) · cites this paper as [152]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Choi, M., Scholl, U. I., Yue, P., Björklund, P., Zhao, B., Nelson-Williams, C. J., Ji, W., Cho, Y., Patel, A. P., Men, C. J., et al. (2011) · Science · doi:10.1126/science.1198785 · Cited by 999
Scholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 574
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Azizan, E. A. B., Poulsen, H., Tuluc, P., Zhou, J., Clausen, M. V., Lieb, A., Maniero, C., Garg, S., Bochukova, E. G., Zhao, W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2716 · Cited by 544
Nishikawa, T., Omura, M., Satoh, F., Shibata, H., Takahashi, K., Tamura, N., & Tanabe, A. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0133 · Cited by 535
Savard, S., Amar, L., Plouin, P.-F., & Steichen, O. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01060 · Cited by 505
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Viola, A., Tizzani, D., Iannaccone, A., Crudo, V. L., Burrello, J., Milan, A., Rabbia, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2805 · Cited by 413
Cited by
Sorted by citations
Items 101–151 of 151
Salle, S. P., Corbeil, G., Haffaf, Z. E., Duranceau, C., Latour, M., Karakiewicz, P. I., Lacroix, A., & Bourdeau, I. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac564 · Cited by 6
A novel clinical-imaging nomogram for predicting primary aldosteronism in patients with hypertension
Liu, Y., Wang, M., Qiu, X., Ma, G., Ji, M., Yang, Y., & Sun, M. (2023) · Hypertension Research · doi:10.1038/s41440-023-01374-z · Cited by 6
A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma
Murakami, M., Yoshimoto, T., Minami, I., Bouchi, R., Tsuchiya, K., Hashimoto, K., Izumiyama, H., Fujii, Y., Endo, T., Akashi, T., et al. (2015) · Endocrine Pathology · doi:10.1007/s12022-015-9400-9 · Cited by 6
Scholl, U. I. (2021) · Der Internist · doi:10.1007/s00108-021-00972-8 · Cited by 6
Zhao, L., Wan, J., Wang, Y., Yang, W., Liang, Q., Wang, J., & Jin, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1068335 · Cited by 5
Recent Development toward the Next Clinical Practice of Primary Aldosteronism: A Literature Review
Tezuka, Y., Yamazaki, Y., Nakamura, Y., Sasano, H., & Satoh, F. (2021) · Biomedicines · doi:10.3390/biomedicines9030310 · Cited by 5
Non-neoplastic/hyperplastic primary aldosteronism – Its histopathology and genotype
Yamazaki, Y., Omata, K., Tezuka, Y., Gao, X., Ogata, H., Pieroni, J., Ono, Y., Morimoto, R., Nakamura, Y., Gómez-Sánchez, C. E., et al. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.006 · Cited by 5
Cellular Senescence in Human Aldosterone-Producing Adrenocortical Cells and Related Disorders
Pieroni, J., Yamazaki, Y., Gao, X., Tezuka, Y., Ogata, H., Omata, K., Ono, Y., Morimoto, R., Nakamura, Y., Satoh, F., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9050567 · Cited by 5
Expression of inflammation-related genes in aldosterone-producing adenomas with KCNJ5 mutation
Murakami, M., Yoshimoto, T., Nakano, Y., Tsuchiya, K., Minami, I., Bouchi, R., Fujii, Y., Nakabayashi, K., Hashimoto, K., Hata, K.-I., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.007 · Cited by 5
Somatic Mutations Associated with Aldosterone-Producing Adenomas (APAs)
Rahman, A. N. A., & Azizan, E. A. B. A. (2025) · Genes · doi:10.3390/genes16070778 · Cited by 5
The predictors of long-term outcomes after targeted therapy for primary Aldosteronism
Chen, Y.-Y., Huang, S., Pan, C., Peng, K., Lin, L., Chan, C., & Shun, C. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.11.005 · Cited by 4
Hu, Z., Chen, X., Cheng, Y., Zhong, P., Li, Q., Zhao, Y. X., Luan, H., Ren, J., Chen, G., & Wang, J. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14874 · Cited by 4
Wang, H., Weng, C., & Chen, H. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2016.97 · Cited by 4
Chen, C., Tsai, C., Hung, C., Tsai, I., Chiu, Y., Chang, C., Liu, K., Liao, S., Wu, V., & Lin, Y. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.06.010 · Cited by 4
Kitamoto, T., Ruike, Y., Koide, H., Inoue, K., Maezawa, Y., Omura, M., Nakai, K., Tsurutani, Y., Saito, J., Kuwa, K., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1372683 · Cited by 4
Chen, X., Li, Q., Huang, L., & Wu, P. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70062 · Cited by 3
Jiang, J., & Liu, Y. (2024) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2024.101928 · Cited by 3
Timeline of Advances in Genetics of Primary Aldosteronism
Meyer, L. S., Reincke, M., & Williams, T. A. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_11 · Cited by 3
Gao, X., Yamazaki, Y., Ono, Y., Satoh, F., Li, F., Zhou, H., & Sasano, H. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.09.001 · Cited by 2
Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism
Mai, X., Kometani, M., Kato, T., Aiga, K., Karashima, S., Aono, D., Konishi, S., Nishimoto, K., Hosomichi, K., Watanabe, A., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0150 · Cited by 2
Long, K. C., & Azizan, E. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1736534 · Cited by 3
Genetic mechanisms of primary aldosteronism
Fayad, M., Cosentino, T., Faedda, N., Boulkroun, S., Zennaro, M., & Fernandes-Rosa, F. L. (2026) · Annales d Endocrinologie · doi:10.1016/j.ando.2026.102558 · Cited by 2
Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center study
Kitamoto, T., Idé, T., Tezuka, Y., Wada, N., Shibayama, Y., Tsurutani, Y., Takiguchi, T., Inoue, K., Suematsu, S., Omata, K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47967-z · Cited by 2
Ma, Y., Tang, X., Ge, Q., Xu, J., Gao, P., Wang, J., & Zhu, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1467742 · Cited by 2
Unmasking primary aldosteronism: Transforming disease management with advanced steroid profiling
Zhong, J., Paljor, T., Yu, S., & Qiu, L. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120186 · Cited by 2
Wang, Z., Luo, J., Guan, L., Wang, J., Chen, J., Xu, L., Li, M., Zuo, R., Bai, H., Xie, Y., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag301 · Cited by 1
Pecori, A., Monticone, S., Losano, I., Cavaglià, G., Pieroni, J., Veglio, F., & Mulatero, P. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-45562-0_5 · Cited by 1
Larger size of Conn’s adenoma is associated with lower cure rates post adrenalectomy
Huang, X. O., Leong, E. K. F., Chan, W. T., Lee, J. W. K., Pinto, D., Yuan, N. K., & Parameswaran, R. (2024) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-024-03553-z · Cited by 1
Genetic aspects of primary hyperaldosteronism and pheochromocytoma
Ворохобина, Н. В., Борисович, Ш. С., Александровна, Б. К., & Камильевна, Г. Р. (2017) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2017-23-3-178-185 · Cited by 1
Scholl, U. I. (2019) · Der Pathologe · doi:10.1007/s00292-019-00682-x · Cited by 1
Genetic Alterations and Molecular Signatures in Aldosterone Producing Adenomas
Åkerström, T. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Primary Aldosteronism: From Genetic Causes to Clinical Guidelines
Nanba, K., Shibata, H., & Rainey, W. E. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_6
Aldosterone-Producing Adenomas; Genetics
Lenzini, L., Zanin, S., & Rossi, G. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11084-0
Germline and somatic genetic basis of primary aldosteronism
Fernandes-Rosa, F. L., Zennaro, M., & Boulkroun, S. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.015
Adrenal Gq Signaling: Implications for Maintenance of Zonation and Steroidogenesis
Taylor, M. J. (2019) · Deep Blue (University of Michigan)
Genetics of Primary Aldosteronism and Other Steroid-Related Causes of Endocrine Hypertension
Zennaro, M., Fernandes-Rosa, F. L., & Boulkroun, S. (2022) · doi:10.1093/med/9780198870197.003.0099
Immunogenetics of primary hyperaldosteronism: fundamental studies and their clinical prospects
Eristavi, S. K., Platonova, N. M., & Troshina, E. A. (2022) · Problems of Endocrinology · doi:10.14341/probl12783
SECONDARY HYPERTENSION: GENES THAT STIMULATE EXCESSIVE SECRETION OF ALDOSTERONE
Nazri, S. K. S. M., & Azizan, E. A. (2022) · Jurnal Sains Kesihatan Malaysia · doi:10.17576/jskm-2022-2001-05
Mineralocorticoids and Mineralocorticoid Excess Syndromes: Clinical Aspects
Freel, E. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65415-6
Primary aldosteronism: where are we now?
Funder, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00019-8
代, 若. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.143954
Mineralocorticoids and mineralocorticoid excess syndromes: Clinical aspects
Freel, E. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00138-2
Lin, N.-T., Chen, T.-Y., Wu, X., Chang, Y., Tsai, C., Liao, C., Lai, T., Chang, C., Lee, B., Lu, C., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-02030-w
Mutation of KCNJ5 induced adrenal aldosterone adenoma via CYP11A1 regulationPreprint
Liu, X., Pang, K., Zou, D., Sun, S., Li, B., Pan, W., Zhu, L., Ye, J., Han, Z., Hu, X., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6215564/v1
Ng, E., Jong, I., Lau, K. K., Akram, M., Morgan, J., Nelva, P., Simpson, I. A., Haskali, M. B., Fuller, P. J., Shen, J., et al. (2026) · Journal of Nuclear Medicine · doi:10.2967/jnumed.125.271006
Genetic mechanisms of primary aldosteronism
Fayad, M., Cosentino, T., Faedda, N., Boulkroun, S., Zennaro, M., & Fernandes-Rosa, F. L. (2026) · Annales d Endocrinologie · doi:10.1016/j.ando.2026.102520
Genetic Basis of Cardiomyopathies Associated with Endocrinopathies: A Comprehensive Review
Concistrè, A., Caramazza, C., D’Abbondanza, M., Santori, R., & Imperoli, G. (2026) · Cardiogenetics · doi:10.3390/cardiogenetics16020008
Aldosterone Suppression Testing and Subtype Prediction for Primary AldosteronismPreprint
Payanundana, M., Parksook, W. W., Piyanirun, K., Charunvarakornchai, D., Siriwan, C., Salle, S. P., Tsai, C., Newman, A. J., Brown, J. M., Sathavarodom, N., et al. (2026) · medRxiv · doi:10.64898/2026.05.14.26353176
Otsubo, Y., Shimada, H., Hoshi, K., Ito, R., Nguyen, T. P., Yamakoshi, H., Ohsawa, K., Ueda, H., Tokuyama, H., Saito, Y., et al. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154584
Metadata
- Authors
- Zheng, F.-F., Zhu, L.-M., Nie, A.-F., Li, X.-Y., Lin, J.-R., Zhang, K., Chen, J., Zhou, W.-L., Shen, Z.-J., Zhu, Y.-C., Wang, J.-G., Zhu, D.-L., & Gao, P.-J.
- Affiliations
- From the State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension and Department of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (F.-F.Z., L.-M.Z., J.C., J.-G.W., D.-L.Z., P.-J.G.); Laboratory of Vascular Biology and Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China (F.-F.Z., J.-R.L., K.Z., P.-J.G.); Shanghai Institute...
- Shanghai Medical College of Fudan University (CN)
- Venue
- Hypertension
- Published
- 2015-03
- Volume
- 65
- Issue
- 3
- Pages
- 622-628
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2116698088
- Cited by
- 151
- References
- 31
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 9 · 2023: 10 · 2022: 11 · 2021: 18 · 2020: 15 · 2019: 15 · 2018: 13 · 2017: 18 · 2016: 15 · 2015: 10
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Shanghai Jiao Tong University
- Ruijin Hospital
- School of Medicine, Shanghai Jiao Tong University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- aldosterone-producing adenoma, somatic mutations, KCNJ5, ATP1A1, ATP2B3, CACNA1D, Chinese patients, aldosterone excretion, serum potassium, potassium channel selectivity, membrane depolarization, calcium signaling
- MeSH terms
- Sodium-Potassium-Exchanging ATPase, Adrenal Cortex Neoplasms, Adult, Aldosterone, Base Sequence, Female, Humans, Male, Middle Aged, Molecular Sequence Data, Mutation, Phenotype, Potassium, Retrospective Studies, Sex Factors, Prevalence, Adrenocortical Adenoma, Calcium Channels, L-Type, Asian People, Tumor Burden, G Protein-Coupled Inwardly-Rectifying Potassium Channels, Plasma Membrane Calcium-Transporting ATPases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
